National Health Service partnership
We work closely with the NHS to build clinical research excellence capacity in the region; through continued professional development (CPD) to build the skills profile of the workforce; and deliver health improvements in a regional context.
Our joint commitment to the highest standards of medical education contributes to the essential modernisation required to deliver the government’s NHS Plan and our region’s requirements. It also ensures the right environment to support the way doctors are trained in line with the General Medical Council’s guidance, 'Tomorrow’s Doctors'.
The Medical School works with the following NHS Trusts and partners to deliver our medical education:
- Royal Devon and Exeter NHS Foundation Trust
- Royal Cornwall Hospitals NHS Trust
- Northern Devon Healthcare NHS Trust
- Torbay and South Devon NHS Foundation Trust
- Devon and Cornwall Partnership Trusts
- GP Practices across Devon and Cornwall
- Northern, Eastern and Western Devon Clinical Commissioning Group
- Health Education England South West
In addition to our work with regional NHS partner Trusts, the College has successfully managed to create numerous research partnerships and has gained significant funding from organisations such as the National Institute for Health Research (NIHR) and the Medical Research Council (MRC) to help build its research capacity steadily in a very testing financial environment.
PenARC is the National Institute for Health Research (NIHR) Applied Research Collaboration (ARC) South West Peninsula.
The NIHR PenTag unit is a team of researchers within Evidence Synthesis & Modelling for Health Improvement (ESMI) that specialise in conducting health technology assessment for national policy makers in England and Wales. PenTAG is one of several university-based research groups in the UK contracted to produce high quality systematic reviews and economic analyses of health technologies for NICE, the UK National Screening Committee and the NIHR HTA programme.
The NIHR Exeter Clinical Research Facility facilitates clinical and translational (from "bench to bedside") research for the benefit of patients in the West Country.
Specifically developed to provide support in the form of facilities and staff to medical researchers in the region, it supports an extensive range of research projects and provides facilities including a vascular medicine research suite, a clinical research suite, molecular biology facilities, an MRI research centre and two treatment rooms adapted for paediatric research.
The main gateway for public participation in CRF research is through the Exeter 10,000 project, which aims to engage 10% of the adult population of Exeter and the surrounding areas in research. This study is a research register and a biobank. By participating in a 30 minute health assessment, volunteers donate samples that may be used hundreds of times in the future by scientists who are studying the causes of disease.
Exeter is the relationship holder for the Peninsula Quintiles Prime site which results in the South West being a preferred partner for clinical trials from Quintiles and also to work strategically with Quintiles to enhance clinical trials delivery in the South West.
The Medical School is a key partner in this project, led by the Royal Devon & Exeter NHS Foundation Trust. It is one of the 11 centres in England that will jointly lead the 100,000 Genomes Project and is anticipated to contribute 4,200 genomes from people living in Devon, Cornwall and Somerset. This landmark project will give new insights into cancer biology, new ways of diagnosing rare disease and new treatments for patients in the NHS and throughout the world.
The network brings together all of the region's NHS Trusts, all four Clinical Commissioning Groups and two Universities to improve and sustain the healthcare system for current and future generations of patients and prioritise funding solutions for problems which affect the largest numbers of patients and put the greatest stress on our health care systems in the South West.